Abstract
Using a humanized mouse model, we developed melanoma specific CD8 T cells from genetically modified human hematopoietic stem cells (hHSC). The transgenic T cells were functional both in vivo and ex vivo, effectively limiting and clearing tumor growth. Finally, the transduced hHSC stably populated the bone marrow. © 2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Vatakis, D. N. (2012). Engineering hematopoietic stem cells to create melanoma specific CTL. OncoImmunology. https://doi.org/10.4161/onci.19408
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free